Patient Selection for Aflibercept 8 mg

Opinion
Video

Panelists discuss how ideal candidates for aflibercept 8 mg include patients with stable disease on current anti-VEGF therapy who seek reduced treatment burden, newly diagnosed patients, and those demonstrating good response to initial loading doses.

Video content above is prompted by the following:

  • Who is the ideal patient for aflibercept 8 mg?
Recent Videos
3 experts are featured in this series.
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
3 experts are featured in this series.
3 experts are featured in this series.
2 experts in this video
2 experts in this video
2 experts in this video
Related Content
© 2025 MJH Life Sciences

All rights reserved.